Health ❯ Public Health

Drug Regulation

Legal Issues Fentanyl Fentanilo Lack of Federal Regulation Mifepristone Schedule I Drugs Cannabis Products Drug Disposal Health Authorities Quality Control FDA Euthanasia Drugs Antimicrobial Resistance Acetaminophen Quality Assurance Quality Testing Kratom Products Safety Reviews Opioid Management Drugs and Cosmetics Cough Syrups Controlled Substances Medication Safety Substance Monitoring Safer Drug Supply Program

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

The FDA describes an evidence‑driven study now in a data‑gathering phase with no projected timeline.

L.A. County Links Six Recent Overdose Deaths to Synthetic 7‑OH Kratom

FDA Moves to Add Pregnancy Warning on Acetaminophen as Experts Counter Link to Autism

L.A. County Issues Warning After Three Deaths Tied to Synthetic Kratom Products

House Subcommittee Advances Nationwide Ban on Hemp-Derived THC Products